{"id":37913,"date":"2017-03-02T06:48:16","date_gmt":"2017-03-02T11:48:16","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=37913"},"modified":"2017-03-02T06:48:16","modified_gmt":"2017-03-02T11:48:16","slug":"microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913","title":{"rendered":"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S."},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Microbot Medical Inc (NASDAQ:MBOT)<\/strong> a medical device firm specializing in the development and design of innovative micro-robotic medical technologies, reported that the USPTO has released a Notice of Allowance for a major technology patent.<\/p>\n<h2 style=\"text-align: justify;\"><strong>The buzz<\/strong><\/h2>\n<p style=\"text-align: justify;\">Two of the inventors are the firm\u2019s co-founders, Professor Moshe Shoham and Harel Gadot. Mr. Gadot is the President, Chairman and CEO of company.\u00a0 Professor Shoham is on the firm\u2019s Board and also a part of the Scientific Advisory Board. He serves as the Head of the Robotics laboratory at the Technion, Israel Institute of Technology. Microbot reported that the patent rights are protected as a joint patent under a limited license deal the firm closed with the Technion.<\/p>\n<p style=\"text-align: justify;\">Microbot\u2019s patent covers methods and systems for decreasing venous stenosis linked with the development of hemodialysis shunts. As per the process, a clearing device is put via a first bore, whereas dialyzed blood returns into the blood vessel via a second bore. This clearing device can work to be a passive device put down in the blood vessel or an autonomous crawling device. The new patent offers an additional layer of cover to Microbot&#8217;s unique ViRob\u2122 and TipCat\u2122 platforms, moving beyond their existing IP protected applications.<\/p>\n<p style=\"text-align: justify;\">Mr. Gadot added that they continue to focus on growing their unique intellectual property assets. The patent allowance released to Microbot by the USPTO protects company\u2019s medical devices for the stoppage of shunt stenosis and will improve their future standing within the shunt industry.<\/p>\n<p style=\"text-align: justify;\">\u00a0They plan to continue to grow their IP assets as they grow their transformational micro-robotic know-how to diagnose and treat grave medical ailments as well as extend and enhance the quality of life for the people suffering from those ailments.<\/p>\n<p style=\"text-align: justify;\">In the last trading session, the stock price of Microbot Medical declined over 7% to close at $6.30.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Microbot Medical Inc (NASDAQ:MBOT) a medical device firm specializing in the development and design of innovative micro-robotic medical technologies, reported that the USPTO has released [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":37914,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[12340,12338,12336,12339,12337],"stock_ticker":[],"class_list":["post-37913","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-harel-gadot","tag-microbot-medical-inc","tag-microbot-medical-inc-nasdaqmbot","tag-moshe-shoham","tag-nasdaqmbot","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S. - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S. - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Microbot Medical Inc (NASDAQ:MBOT) a medical device firm specializing in the development and design of innovative micro-robotic medical technologies, reported that the USPTO has released [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-03-02T11:48:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S.\",\"datePublished\":\"2017-03-02T11:48:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913\"},\"wordCount\":319,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png\",\"keywords\":[\"Harel Gadot.\",\"Microbot Medical Inc\",\"Microbot Medical Inc (NASDAQ:MBOT)\",\"Moshe Shoham\",\"NASDAQ:MBOT\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913\",\"name\":\"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S. - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png\",\"datePublished\":\"2017-03-02T11:48:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png\",\"width\":400,\"height\":200,\"caption\":\"Microbot Medical Inc\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S. - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913","og_locale":"en_US","og_type":"article","og_title":"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S. - Wall Street PR","og_description":"Microbot Medical Inc (NASDAQ:MBOT) a medical device firm specializing in the development and design of innovative micro-robotic medical technologies, reported that the USPTO has released [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2017-03-02T11:48:16+00:00","og_image":[{"width":400,"height":200,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png","type":"image\/png"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S.","datePublished":"2017-03-02T11:48:16+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913"},"wordCount":319,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png","keywords":["Harel Gadot.","Microbot Medical Inc","Microbot Medical Inc (NASDAQ:MBOT)","Moshe Shoham","NASDAQ:MBOT"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913","url":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913","name":"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S. - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png","datePublished":"2017-03-02T11:48:16+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2017\/03\/Microbot-Medical-Inc.png","width":400,"height":200,"caption":"Microbot Medical Inc"},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/microbot-medical-inc-nasdaqmbot-reports-technology-patent-allowance-in-the-u-s-37913#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Microbot Medical Inc (NASDAQ:MBOT) Reports Technology Patent Allowance in the U.S."}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37913","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=37913"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/37913\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/37914"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=37913"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=37913"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=37913"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=37913"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}